New England Biolabs, CasZyme Collaborate to Identify, Commercialize CRISPR-Cas Nucleases – GenomeWeb
|
New England Biolabs, CasZyme Collaborate to Identify, Commercialize CRISPR-Cas Nucleases
GenomeWeb NEW YORK (GenomeWeb) – New England Biolabs and startup company CasZyme announced today that they have formed a multi-year collaboration to identify and commercialize CRISPR-Cas nucleases. Under the terms of the agreement, the two companies will work to … New England Biolabs® and CasZyme collaborate to enable genome editing applications with novel Cas9 Enzymes |
